Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Transplantation|November 14, 2008
Differentiation of mouse hepatic progenitor cells induced by hepatocyte nuclear factor-4 and cell transplantation in mice with liver fibrosisAtsushi Suetsugu, Masahito Nagaki, Hitomi Aoki, et al.
Anticancer Research|October 15, 2013
Imaging nuclear - cytoplasm dynamics of cancer cells in the intravascular niche of live miceAtsushi Suetsugu, Ping Jiang, Hisataka Moriwaki, et al.
Anticancer Research|December 26, 2012
Subcellular real-time imaging of the efficacy of temozolomide on cancer cells in the brain of live miceMasashi Momiyama, Atsushi Suetsugu, Takashi Chishima, et al.
Advanced Drug Delivery Reviews|August 28, 2012
Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse modelsAtsushi Suetsugu, Kimi Honma, Shigetoyo Saji, et al.
Nutrients|September 23, 2017
Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle VolumeKenji Imai, Koji Takai, Satoshi Watanabe, et al.
Anticancer Research|May 13, 2015
Imaging the Interaction of Pancreatic Cancer and Stellate Cells in the Tumor Microenvironment during MetastasisAtsushi Suetsugu, Cynthia S Snyder, Hisataka Moriwaki, et al.
Cancers|January 26, 2024
Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does NotKenji Imai, Koji Takai, Shinji Unome, et al.
Molecular and Clinical Oncology|September 18, 2023
FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinomaKenji Imai, Koji Takai, Shinji Unome, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 14, 2019
Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysisTatsunori Hanai, Makoto Shiraki, Kenji Imai, et al.
Cancers|September 9, 2023
Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying CovariatesKenji Imai, Koji Takai, Shinji Unome, et al.
Pageof 13